MS patients to test cannabis
The Scotsman Fri, 30 Jun 2006 5:00 AM PDT
PATIENTS are being recruited for a trial to determine whether chemicals in cannabis can slow the impact of multiple sclerosis.

EU Approves Sale of MS Drug Tysabri Newsday Thu, 29 Jun 2006 1:11 PM PDT The U.S. and Irish makers of Tysabri, a highly touted drug used to suppress the effects of multiple sclerosis, said Thursday that European Union authorities have cleared the way for the drug's sale throughout the 25-nation bloc.

Biogen Idec/Elan: a New Market for Tysabri
RedNova Thu, 29 Jun 2006 12:14 PM PDT
Biogen Idec and Elan's multiple sclerosis drug Tysabri has received EU approval for the treatment of relapsing remitting MS and the companies now expect to launch the drug first in Ireland in July 2006.